Patents Assigned to BASF Aktiengesellsschaft
  • Method for the Production of Single-and/or Multiple-Coated Substrates
    Publication number: 20080248321
    Abstract: A process for the production of singly and/or multiply coated paper and/or board, except for photographic papers and self-adhesive labeling papers, which are particularly suitable for printing, packaging and inscription, is described. The substrate, for example base paper or board, is coated once or several times with a free-falling liquid curtain, the coating liquid having in particular an extensional viscosity of from 1 to 1000 Pa·s at a Hencky strain of from 1 to 15.
    Type: Application
    Filed: September 15, 2005
    Publication date: October 9, 2008
    Applicant: BASF Aktiengesellsschaft
    Inventors: Erich Krumbacher, Norbert Willenbacher, Oliver Birkert, Martin Schachtl, Christoph Hamers, Martin Tietz, Uwe Froehlich
  • Fungicidal mixtures
    Publication number: 20070129384
    Abstract: Fungicidal mixtures comprising, as active components, 1) the triazolopyrimidine derivative of the formula I, ?and 2) carbendazim of the formula II, ?in a synergistically effective amount, methods for controlling harmful fungi using mix-tures of the compound I with the compound II, the use of the compound I with the compound II for preparing such mixtures and compositions comprising these mixtures are described.
    Type: Application
    Filed: October 27, 2004
    Publication date: June 7, 2007
    Applicant: BASF Aktiengesellsschaft
    Inventors: Jordi Tormo i Blasco, Thomas Grote, Maria Scherer, Reinhard Stierl, Siegfried Strathmann, Ulrich Schofl
  • Hydroxamate inhibitors of interleukin-1.beta. converting enzyme
    Patent number: 5919790
    Abstract: The present invention relates to compounds that are inhibitors of interleukin-1.beta. converting enzyme that have the Formula II ##STR1## This invention also relates to a method of treatment of stroke, inflammatory diseases, septic shock, reperfusion injury, Alzheimer's disease, shigellosis, and to a pharmaceutically acceptable composition that contains a compound that is an inhibitor of interleukin-1.beta. converting enzyme.
    Type: Grant
    Filed: October 2, 1997
    Date of Patent: July 6, 1999
    Assignees: Warner-Lambert Company, BASF Aktiengesellsschaft
    Inventors: Hamish John Allen, Kenneth Dale Brady, Bradley William Caprathe, Paul Galatsis, John Lodge Gilmore, Sheryl Jeanne Hays, Robert Vincent Talanian, Nigel Walker, Joseph Scott Warmus